Archimed reaches €100m first close for maiden healthcare fund
Archimed, a new France-based GP set up by former 3i executives, has held a first close on €100m for its maiden healthcare-focused fund, Med I FIA.
The vehicle has a €120m target and is being raised with the help of placement agent Triago.
Archimed was set up at the end of last year by Denis Ribon, the former global head of healthcare at 3i, as well as three members of his former team. Ribon had been on gardening leave since mid-December 2013 but was allowed to start raising the vehicle, which officially held its first close at the beginning of April.
Investors
Med I FIA has so far attracted 15 institutional and private investors from across the globe.
Investments
Archimed's maiden fund will focus exclusively on the European healthcare space, targeting subsectors such as medtech, biopharma and healthcare providers. The fund will mainly invest in lower mid-cap leveraged buyout transactions with equity tickets in the €5-15m range. It will only target profitable businesses.
The firm stated it was already working on several transactions in France, Switzerland and the UK. According to one of the founders' LinkedIn profile, Archimed will look to complete around 15 investments over its lifespan.
People
Denis Ribon, Vincent Guillaumot, Cédric Berger and David Piccoli are the co-founders of Archimed.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater